RiboCeine is a unique compound that effectively supports endogenous Glutathione production. Through a patented bonding of D-ribose and L-cysteine, the technology of RiboCeine allows for cysteine to be more easily absorbed through the digestive system, to then be absorbed into the bloodstream and deliver intact Cysteine and Ribose directly to the cells.

This not only supports Glutathione production through direct supplementation of Cysteine, it provides Ribose as an integral component of Adenosine triphosphate (ATP) – the cells’ natural fuel and source of energy.

Researched and developed over a period of 25 years, RiboCeine has been the subject of fifty-four independent, third-party studies funded by the Veterans Administration, National Institutes of Health and other scientific funding agencies.

Published in peer-reviewed journals, RiboCeine has significantly outperformed other means of glutathione enhancement against which it has been tested and has been shown to be up to 300% more effective than the next best common treatment – N-Acetyl Cysteine (NAC) – in raising Glutathione levels in this liver cell model.¹

¹ Roberts JC. Et Al. Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity, 2-(polyhydroxyalky)-and 2-(Polyacetoxyalky)-Thiazolidine-4(R)-Carboxylic Acids, J. Med Chem. 1987, 30, 1891-1896.